Bristol-Myers Squibb Co (NYSE:BMY)
| 50.24 Delayed Data As of 4:00pm ET |  +0.255 / +0.51%Today’s Change | 48.25 Today|||52-Week Range 81.42 | -30.18% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 49.98 |
| Today’s open | 49.81 |
| Day’s range | 49.56 - 50.40 |
| Volume | 12,655,567 |
| Average volume (3 months) | 12,484,401 |
| Market cap | $101.9B |
Data as of 4:00pm ET, 12/05/2023
Growth & Valuation
| Earnings growth (last year) | -5.67% |
| Earnings growth (this year) | +3.78% |
| Earnings growth (next 5 years) | -0.37% |
| Revenue growth (last year) | -0.49% |
| P/E ratio | 12.7 |
| Price/Sales | 3.35 |
| Price/Book | 3.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRTXVertex Pharmaceutica... | +3.60 | +1.03% |
| REGNRegeneron Pharmaceut... | -2.19 | -0.27% |
| SNYSanofi | -0.66 | -1.40% |
| ZTSZoetis Inc | -2.45 | -1.35% |
Data as of 4:00pm ET, 12/05/2023
Financials
| Next reporting date | February 2, 2024 |
| EPS forecast (this quarter) | $1.95 |
| Annual revenue (last year) | $46.2B |
| Annual profit (last year) | $6.3B |
| Net profit margin | 13.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Princeton, New Jersey |
Forecasts
